Pub. Date : 2016
PMID : 28078290
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Elevated NO x level was observed in patients who received the first-line disease-modifying therapy (interferons beta-1a and beta-1b) in comparison with the subjects treated with the second-line disease-modifying therapy (natalizumab; fingolimod) and healthy controls without significant differences in C-reactive protein and interleukin-1 beta. | nicotine 1-N-oxide | interleukin 1 beta | Homo sapiens |